Michael Lishner
Impact in
- Oncology top 1%
- Cancer Risks and Factors
- Hematology top 1%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 62
- Cancer Risks and Factors 33
- Co-authors
- Gideon Koren (18 shared papers)David Pereg (20 shared papers)Mordchai Ravid (28 shared papers)Liat Drucker (45 shared papers)Avi Leader (11 shared papers)Avishay Elis (38 shared papers)Judith Radnay (28 shared papers)Aliza Amiel (33 shared papers)
- Journals
- Anti-Cancer Drugs (6 papers)Blood (5 papers)Acta Haematologica (5 papers)Human Reproduction (5 papers)Journal of Investigative Medicine (4 papers)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Michael Lishner
233 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 143
- Oncology 2.1k
- Hematology 696
- Genetics 542
- Hepatology 233
- Obstetrics and Gynecology 217
Countries citing papers authored by Michael Lishner
This map shows the geographic impact of Michael Lishner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lishner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lishner more than expected).
Fields of papers citing papers by Michael Lishner
This network shows the impact of papers produced by Michael Lishner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lishner. The network helps show where Michael Lishner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lishner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 259 | |
| 2 | 2012 | 204 | |
| 3 | 1987 | 169 | |
| 4 | 1992 | 141 | |
| 5 | 2010 | 129 | |
| 6 | 1990 | 121 | |
| 7 | 2012 | 111 | |
| 8 | 2001 | 99 | |
| 9 | 1991 | 98 | |
| 10 | 2008 | 98 | |
| 11 | 2005 | 97 | |
| 12 | 1992 | 96 | |
| 13 | 2001 | 92 | |
| 14 | Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. | 1990 | 87 |
| 15 | 1995 | 81 | |
| 16 | 2004 | 79 | |
| 17 | 2004 | 79 | |
| 18 | 1990 | 74 | |
| 19 | 1990 | 74 | |
| 20 | 1990 | 73 |
About Michael Lishner
Michael Lishner is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Pathology and Forensic Medicine, having authored 239 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Risks and Factors (33 papers), Chronic Lymphocytic Leukemia Research (25 papers), Multiple Myeloma Research and Treatments (24 papers), Lymphoma Diagnosis and Treatment (16 papers), Acute Lymphoblastic Leukemia research (15 papers), Genomic variations and chromosomal abnormalities (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). The work is most often cited by research in Oncology (2.1k citations), Hematology (696 citations), Genetics (542 citations), Hepatology (233 citations) and Obstetrics and Gynecology (217 citations). Michael Lishner has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Gideon Koren, David Pereg, Mordchai Ravid, Liat Drucker, Avi Leader, Avishay Elis, Judith Radnay, Aliza Amiel, Donna Zemlickis and Moshe Fejgin. Their work appears in journals such as Anti-Cancer Drugs, Blood, Acta Haematologica, Human Reproduction and Journal of Investigative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.